ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
페노바르비탈 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 5.2%의 CAGR로 19억 1,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 제네릭 의약품 제조 확대, 신경 질환 관리에 대한 관심 증가, 디지털 공급망 및 e-약국 성장, 제네릭 의약품 사용을 지지하는 규제 변경, 제네릭 의약품 규제 경로의 안정성과 관련이 있습니다. 예측 기간의 주요 동향으로는 투여하기 쉬운 전달 형태 개발, R&D 혁신, 서방형 제제, 강화된 약물전달 시스템, 생산 기술 향상에 대한 투자 등을 꼽을 수 있습니다.
간질 유병률의 증가는 페노바르비탈 시장의 성장을 견인할 것으로 예상됩니다. 간질은 뇌의 비정상적인 활동으로 인해 유발되지 않는 발작이 반복적으로 발생하는 신경질환입니다. 간질 유병률이 증가하고 있는 배경에는 인지도가 높아지면서 증상을 인지하고 의료기관을 찾는 사람들이 증가하여 보고 건수가 증가하고 있는 것도 한 요인으로 작용하고 있습니다. 항경련제인 페노바르비탈은 뇌 내 신경세포의 활동을 둔화시켜 발작을 억제합니다. 예를 들어, 미국 질병예방통제센터(CDC)가 2024년 5월에 발표한 보고서에 따르면, 2021-2022년 사이 미국에서는 성인 인구의 약 1%에 해당하는 약 290만 명의 성인이 활동성 간질을 앓고 있다고 합니다. 이에 따라 간질 유병률 증가가 페노바르비탈의 수요를 견인할 것으로 예상됩니다.
페노바르비탈 시장의 주요 기업들은 페노바르비탈 나트륨과 같은 새로운 치료법을 개발하여 치료의 안전성과 효능을 향상시키는 데 주력하고 있습니다. 페노바르비탈 나트륨은 페노바르비탈의 나트륨 염으로 일반적으로 항경련제 및 진정제로 사용됩니다. 2023년 1월, 인도에 본사를 둔 제약회사 Sun Pharmaceutical Industries Ltd.는 미국에서 SEZABY를 출시했으며, 이는 FDA가 승인한 최초의 약물로, 임신 말기 및 조산 신생아의 발작을 치료하기 위해 특별히 고안되었습니다. SEZABY는 벤질 알코올과 프로필렌 글리콜을 포함하지 않아 신생아에게 더 안전하게 사용할 수 있습니다. 이 약은 희귀의약품으로 지정되었으며, 신생아 발작 조절에 효과적이라는 임상 데이터를 통해 이 취약한 환자군의 중요한 미충족 수요를 충족시킬 수 있다는 것을 입증했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 페노바르비탈 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 페노바르비탈 시장 : 성장률 분석
세계의 페노바르비탈 시장 실적 : 규모와 성장, 2019-2024
세계의 페노바르비탈 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 페노바르비탈 전체 시장(TAM)
제6장 시장 세분화
세계의 페노바르비탈 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
간질
신생아 발작
세계의 페노바르비탈 시장 : 제형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
정제
캡슐
주사제
세계의 페노바르비탈 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 페노바르비탈 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
발작 관리
마취
수면장애
알코올 금단 증후군
세계의 페노바르비탈 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
연구소
재택 케어 환경
세계의 페노바르비탈 시장, 간질, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
국소 (부분) 발작
전신성 강직-간대성 발작
뇌전증 지속증
난치성 간질
특발성 간질
세계의 페노바르비탈 시장, 신생아 발작, 유형별 하위 세분화 : 실적과 예측, 2019-2024, 2024-2029F, 2034F
저산소성 허혈성뇌증(HIE) 유발성 발작
두개내출혈 유발성 발작
대사장애
선천성 뇌기형
감염증
제7장 지역별·국가별 분석
세계의 페노바르비탈 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 페노바르비탈 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
페노바르비탈 시장 : 경쟁 구도
페노바르비탈 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Teva Pharmaceutical Industries Ltd.
Fresenius Kabi AG
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Lupin Limited
H. Lundbeck A/S
Sandoz Group AG
Yashiro Pharmaceutical Co. Ltd.
Hikma Pharmaceuticals PLC
Par Pharmaceutical Inc.
Shandong Xinhua Pharmaceutical Co. Ltd.
Manus Aktteva Biopharma LLP
JPN Pharma Pvt. Ltd.
Alkaloida Chemical Company Zrt.
Harman Finochem Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
페노바르비탈 시장 2029 : 새로운 기회를 제공하는 국가
페노바르비탈 시장 2029 : 새로운 기회를 제공하는 부문
페노바르비탈 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Phenobarbital is a long-acting barbiturate medication primarily used to control and prevent seizures, especially in the treatment of epilepsy. It is occasionally prescribed as a sedative for anxiety or to manage withdrawal symptoms. It works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve activity in the brain, leading to a calming effect on the central nervous system and a reduced risk of seizures.
The main indications for phenobarbital are epilepsy and neonatal seizures. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. It is available in various dosage forms such as tablets, capsules, and injectables, and is distributed through hospital pharmacies, retail pharmacies, and online pharmacies. It is used in seizure management, anesthesia, sleep disorders, and alcohol withdrawal syndrome, serving a range of end users, including hospitals, clinics, research laboratories, and homecare settings.
The phenobarbital market research report is one of a series of new reports from The Business Research Company that provides phenobarbital market statistics, including phenobarbital industry global market size, regional shares, competitors with a phenobarbital market share, detailed phenobarbital market segments, market trends and opportunities, and any further data you may need to thrive in the phenobarbital industry. This phenobarbital market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phenobarbital market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to the widespread use in epilepsy management, the prevalence of epilepsy and seizure disorders, government supply programs, increasing demand in veterinary applications, and efforts toward achieving universal health coverage.
The phenobarbital market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period can be linked to the expansion of generic drug manufacturing, growing focus on neurological disease management, digital supply chain and e-pharmacy growth, regulatory changes favoring generic use, and stability in regulatory pathways for generics. Key trends in the forecast period include the development of easy-to-administer delivery forms, innovation in research and development, extended-release formulations, enhanced drug delivery systems, and investments in improving production techniques.
The rising prevalence of epilepsy is anticipated to drive the growth of the phenobarbital market. Epilepsy is a neurological condition marked by recurring, unprovoked seizures caused by abnormal brain activity. The increasing incidence of epilepsy is partly due to greater awareness, leading more individuals to recognize symptoms and seek medical attention, resulting in more reported cases. Phenobarbital, an anticonvulsant medication, helps control seizures by slowing down the activity of neurons in the brain. For example, a report from the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that between 2021 and 2022, around 2.9 million adults in the U.S. were living with active epilepsy, representing approximately 1% of the adult population. As a result, the growing prevalence of epilepsy is expected to drive the demand for phenobarbital.
Key companies in the phenobarbital market are focusing on developing new treatments, such as phenobarbital sodium, to improve both the safety and effectiveness of therapies. Phenobarbital sodium is the sodium salt form of phenobarbital, commonly used as an anticonvulsant and sedative. It is primarily prescribed to manage seizures, especially in conditions such as epilepsy, and can also be used to treat anxiety, insomnia, and to induce sedation before medical procedures. In January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S. This was the first FDA-approved medication specifically designed to treat seizures in both term and preterm neonates. SEZABY is free of benzyl alcohol and propylene glycol, making it safer for use in newborns. The drug received orphan drug designation and is supported by clinical data demonstrating its effectiveness in controlling neonatal seizures, addressing a critical unmet need in this vulnerable patient group.
In November 2022, Sun Pharmaceutical Industries Ltd. partnered with SPARC, an India-based biopharmaceutical company, to commercialize phenobarbital for injection in the U.S. This collaboration focuses on marketing a benzyl alcohol- and propylene glycol-free phenobarbital sodium injection to address the unmet need for an FDA-approved treatment for neonatal seizures, while also reducing the risk of neonatal gasping syndrome. SPARC specializes in developing innovative therapeutics.
Major players in the phenobarbital market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, H. Lundbeck A/S, Sandoz Group AG, Yashiro Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, Par Pharmaceutical Inc., Shandong Xinhua Pharmaceutical Co. Ltd., Manus Aktteva Biopharma LLP, JPN Pharma Pvt. Ltd., Alkaloida Chemical Company Zrt., Harman Finochem Ltd.
North America was the largest region in the phenobarbital market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in phenobarbital report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the phenobarbital market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The phenobarbital market consists of sales of products including phenobarbital tablets, phenobarbital oral elixir, phenobarbital injectables, veterinary phenobarbital products, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Phenobarbital Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on phenobarbital market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for phenobarbital ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The phenobarbital market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Indication: Epilepsy; Neonatal Seizures
2) By Dosage Forms: Tablets; Capsules; Injectables
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Phenobarbital Market Characteristics
3. Phenobarbital Market Trends And Strategies
4. Phenobarbital Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Phenobarbital Growth Analysis And Strategic Analysis Framework
5.1. Global Phenobarbital PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Phenobarbital Market Growth Rate Analysis
5.4. Global Phenobarbital Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Phenobarbital Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Phenobarbital Total Addressable Market (TAM)
6. Phenobarbital Market Segmentation
6.1. Global Phenobarbital Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epilepsy
Neonatal Seizures
6.2. Global Phenobarbital Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Injectables
6.3. Global Phenobarbital Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Phenobarbital Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Seizure Management
Anesthesia
Sleep Disorders
Alcohol Withdrawal Syndrome
6.5. Global Phenobarbital Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Laboratories
Homecare Settings
6.6. Global Phenobarbital Market, Sub-Segmentation Of Epilepsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Focal (Partial) Seizures
Generalized Tonic-Clonic Seizures
Status Epilepticus
Refractory Epilepsy
Idiopathic Epilepsy
6.7. Global Phenobarbital Market, Sub-Segmentation Of Neonatal Seizures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
